WO2006055004A8 - Nucleic acids and corresponding proteins entitled 158p3d2 useful in treatment and detection of cancer - Google Patents
Nucleic acids and corresponding proteins entitled 158p3d2 useful in treatment and detection of cancerInfo
- Publication number
- WO2006055004A8 WO2006055004A8 PCT/US2004/039083 US2004039083W WO2006055004A8 WO 2006055004 A8 WO2006055004 A8 WO 2006055004A8 US 2004039083 W US2004039083 W US 2004039083W WO 2006055004 A8 WO2006055004 A8 WO 2006055004A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cancer
- useful
- detection
- treatment
- nucleic acids
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 5
- 206010028980 Neoplasm Diseases 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 title abstract 3
- 201000011510 cancer Diseases 0.000 title abstract 2
- 238000001514 detection method Methods 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 title 1
- 239000012634 fragment Substances 0.000 abstract 2
- 230000024932 T cell mediated immunity Effects 0.000 abstract 1
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 230000028996 humoral immune response Effects 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
A novel gene 158P3D2 and its encoded protein, and variants thereof, are described wherein 158P3D2 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table 1. Consequently, 158P3D2 provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 158P3D2 gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 158P3D2 can be used in active or passive immunization.
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04811746A EP1824877A1 (en) | 2004-11-19 | 2004-11-19 | Nucleic acids corresponding proteins entitled 158p3d2 useful in treatment and detection of cancer |
| PCT/US2004/039083 WO2006055004A1 (en) | 2004-11-19 | 2004-11-19 | Nucleic acids and corresponding proteins entitled 158p3d2 useful in treatment and detection of cancer |
| CA002588564A CA2588564A1 (en) | 2004-11-19 | 2004-11-19 | Nucleic acids and corresponding proteins entitled 158p3d2 useful in treatment and detection of cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2004/039083 WO2006055004A1 (en) | 2004-11-19 | 2004-11-19 | Nucleic acids and corresponding proteins entitled 158p3d2 useful in treatment and detection of cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2006055004A1 WO2006055004A1 (en) | 2006-05-26 |
| WO2006055004A8 true WO2006055004A8 (en) | 2006-09-28 |
Family
ID=34959621
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2004/039083 WO2006055004A1 (en) | 2004-11-19 | 2004-11-19 | Nucleic acids and corresponding proteins entitled 158p3d2 useful in treatment and detection of cancer |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1824877A1 (en) |
| CA (1) | CA2588564A1 (en) |
| WO (1) | WO2006055004A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11596652B2 (en) | 2015-02-18 | 2023-03-07 | Enlivex Therapeutics R&D Ltd | Early apoptotic cells for use in treating sepsis |
| US11318163B2 (en) | 2015-02-18 | 2022-05-03 | Enlivex Therapeutics Ltd | Combination immune therapy and cytokine control therapy for cancer treatment |
| US11497767B2 (en) | 2015-02-18 | 2022-11-15 | Enlivex Therapeutics R&D Ltd | Combination immune therapy and cytokine control therapy for cancer treatment |
| US11304976B2 (en) | 2015-02-18 | 2022-04-19 | Enlivex Therapeutics Ltd | Combination immune therapy and cytokine control therapy for cancer treatment |
| US11000548B2 (en) | 2015-02-18 | 2021-05-11 | Enlivex Therapeutics Ltd | Combination immune therapy and cytokine control therapy for cancer treatment |
| IL284985B2 (en) | 2015-02-18 | 2023-03-01 | Enlivex Therapeutics R& D Ltd | Combination immune therapy and cytokine control therapy for cancer treatment |
| JP6803339B2 (en) | 2015-04-21 | 2020-12-23 | エンリヴェックス セラピューティクス リミテッド | Therapeutic pooled blood apoptotic cell preparations and their use |
| US11730761B2 (en) | 2016-02-18 | 2023-08-22 | Enlivex Therapeutics Rdo Ltd | Combination immune therapy and cytokine control therapy for cancer treatment |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1383922A4 (en) * | 2001-04-10 | 2005-03-30 | Agensys Inc | NUCLEIC ACID AND CORRESPONDING PROTEIN ENTITLED 158P3D2 USEFUL IN THE TREATMENT AND DETECTION OF CANCER |
-
2004
- 2004-11-19 EP EP04811746A patent/EP1824877A1/en not_active Withdrawn
- 2004-11-19 CA CA002588564A patent/CA2588564A1/en not_active Abandoned
- 2004-11-19 WO PCT/US2004/039083 patent/WO2006055004A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| EP1824877A1 (en) | 2007-08-29 |
| WO2006055004A1 (en) | 2006-05-26 |
| CA2588564A1 (en) | 2006-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2004016734A3 (en) | Nucleic acids and corresponding proteins entitled 282p1g3 useful in treatment and detection of cancer | |
| WO2003022995A3 (en) | Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer | |
| WO2003040340A3 (en) | Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer | |
| WO2004098515A3 (en) | Nucleic acids and corresponding proteins entitled 109p1d4 useful in treatment and detection of cancer | |
| EP2280030A3 (en) | Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers | |
| WO2006105488A3 (en) | Antibodies and related molecules that bind to 161p2f10b proteins | |
| WO2005014780A3 (en) | Prostate stem cell antigen (psca) variants and subsequences thereof | |
| IL181218A0 (en) | Nucleic acids and corresponding 58p1d12 proteins for use in the detection and treatment of cancer | |
| WO2009033094A3 (en) | Antibodies and related molecules that bind to 24p4c12 proteins | |
| WO2003050255A3 (en) | Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer | |
| CY1113064T1 (en) | NUCLEAR ACID AND CORRESPONDING PROTEIN WITH TITLE 184P1E2 USEFUL IN CANCER TREATMENT AND DETECTION | |
| WO2002072785A3 (en) | Nucleic acid and corresponding protein entitled 125p5c8 useful in treatment and detection of cancer | |
| WO2004067716A3 (en) | Nucleic acids and corresponding proteins entitled 254p1d6b useful in treatment and detection of cancer | |
| WO2005118864A3 (en) | Antibodies and related molecules that bind to psca proteins | |
| WO2002060953A3 (en) | Nucleic acid and encoded zinc transporter protein entitled 108p5h8 useful in treatment and detection of cancer | |
| WO2006055004A8 (en) | Nucleic acids and corresponding proteins entitled 158p3d2 useful in treatment and detection of cancer | |
| WO2002083928A3 (en) | Nucleid acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer | |
| WO2002092842A3 (en) | Nucleic acids and corresponsing proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer | |
| WO2004050828A3 (en) | Nucleic acid corresponding protein entitled 24p4c12 useful in treatment and detection of cancer | |
| WO2004021977A3 (en) | Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer | |
| WO2002095009A3 (en) | Nucleic acid and corresponding protein entitled 121p1f1 useful in treatment and detection of cancer | |
| WO2003085081A3 (en) | Nucleic acid and corresponding protein entitled 238p1b2 useful in treatment and detection of cancer | |
| WO2002083068A8 (en) | Nucleic acid and corresponding protein entitled 121p2a3 useful in treatment and detection of cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
| DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2588564 Country of ref document: CA |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2004811746 Country of ref document: EP |
|
| WWP | Wipo information: published in national office |
Ref document number: 2004811746 Country of ref document: EP |